BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · IEX Real-Time Price · USD
0.721
-0.079 (-9.88%)
Jul 22, 2024, 9:54 AM EDT - Market open
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$377,204
Market Cap
13.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Centogene | 384 |
| Universe Pharmaceuticals INC | 225 |
| Star Equity Holdings | 171 |
| Flora Growth | 108 |
| Evaxion Biotech | 49 |
| Talphera | 15 |
| XTL Biopharmaceuticals | 7 |
| Immuron | 6 |
BCTX News
- 4 days ago - BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer - GlobeNewsWire
- 7 weeks ago - BriaCell Presents Clinical Efficacy Data at ASCO 2024 - GlobeNewsWire
- 2 months ago - BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024 - GlobeNewsWire
- 2 months ago - BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering - GlobeNewsWire
- 3 months ago - BriaCell Announces Oral and Poster Presentations at ASCO 2024 - GlobeNewsWire
- 3 months ago - BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer - GlobeNewsWire
- 4 months ago - BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies - GlobeNewsWire